Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation

[Business Wire] – Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that it has received approval from the United States Food and Drug Administration for its THERMOCOOL® SMARTTOUCH® Cathet more

View todays social media effects on JNJ

View the latest stocks trending across Twitter. Click to view dashboard

See who Johnson is hiring next, click here to view